PDPN and melanoma: Together, our integrated transcriptomic and proteomic analyses support a mechanistic model in which PDPN activates Wnt/β-catenin signaling, leading to transcriptional upregulation of PD-L1 and contributing to the formation of an immunosuppressive microenvironment in melanoma.